Ellipses Pharma
Signal active
Organization
Contact Information
Overview
Ellipses Pharma is a drug development business specializing in the creation of novel cancer drugs and therapies. Ellipses invests in cancer assets, not companies. Its goal is to bring these exceptional assets into the clinic as soon as possible in order to create more possibilities, run more studies, and save more lives.
About
Industries
Biotechnology
Founded
2015
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Ellipses Pharma headquartered in Europe, operates in the Biotechnology sector. With a team of 11-50 employees, Ellipses Pharma is actively contributing to advancements in Biotechnology. Their latest funding round, Private Equity Round - Ellipses Pharma, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
1
Lead Investors
0
Total Funding Amount
$0
Details
1
Ellipses Pharma has raised a total of $0 in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Private Equity |
Investors
Ellipses Pharma is funded by 3 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Sir Tom Hunter | - | FUNDING ROUND - Sir Tom Hunter | undefined |
| Ellipses Pharma | - | FUNDING ROUND - Ellipses Pharma | undefined |
| West Coast Capital | - | FUNDING ROUND - West Coast Capital | undefined |
Recent Activity
There is no recent news or activity for this profile.